Norwest Venture Partners is a global venture capital and growth equity firm that backs technology-driven companies across consumer, enterprise, and healthcare. Founded in 1961 and based in Palo Alto, California, the firm has invested in more than 600 companies and partnered with over 140 active portfolio companies, offering strategic guidance, operating experience, and a broad network to help CEOs scale. It participates across funding stages from seed to growth, targeting sectors including software, cloud infrastructure, IT services, fintech, and healthcare, and emphasizes long-term partnerships to build enduring businesses.

RA Capital Management is a Boston-based investment firm that provides multi-stage capital to public and private healthcare, life sciences, and planetary health companies. The firm supports management teams from early seed rounds to later financings, seeking to drive value through scientific and clinical data, product development, and commercialization. It complements capital with value-added services such as board representation, executive recruitment, and market intelligence through its TechAtlas research platform. The company also operates Raven, a healthcare incubator that helps entrepreneurs build biomedical ventures, and emphasizes a collaborative, data-driven approach and long-term relationships. RA Capital pursues social responsibility by advocating for affordable medicines and industry advancement, and it invests across U.S. and European opportunities, including early-stage and growth-stage rounds.

MassVentures is a Massachusetts-based venture capital firm that provides seed and early-stage funding to high-growth startups in the Massachusetts innovation economy, helping concepts move from idea to commercialization. Founded in 1978 as a quasi-public corporation by the Legislature of the Commonwealth, it is governed by an independent board and managed by experienced venture investors. The firm focuses on information technology, healthcare, cybersecurity, e-commerce, mobile, manufacturing, and robotics sectors in Massachusetts and operates accelerator programs to support portfolio companies. MassVentures leverages the state's entrepreneurial ecosystem, educated workforce, and centers of innovation to back early-stage ventures.

General Catalyst is a venture capital firm founded in 2000 and based in Cambridge, Massachusetts, with additional offices in North America and Europe. It provides seed to growth-stage investments in technology companies, with emphasis on software, consumer and enterprise applications, fintech, crypto, health tech, and AI-enabled businesses. The firm supports portfolio companies with capital, strategic guidance, mentorship and operational assistance to help them scale and innovate across industries, including healthcare, fintech and consumer technology. General Catalyst manages multiple venture funds and pursues both early-stage and growth investments, often taking minority to majority equity positions. The firm has a global reach and a history of backing companies that become industry leaders, with ongoing focus on resilience and applied AI.

Atlas Venture is a Cambridge-based venture capital firm with a 30-year history of building life sciences companies. Founded in 1980, it focuses on early-stage opportunities in biotechnology, biopharmaceuticals, diagnostics, medical devices, and related life sciences, as well as technology sectors. The firm uses a seed-led venture creation approach and often leads initial rounds, providing strategic guidance and board representation to portfolio companies. Its portfolio has included the development of more than 25 medicines and the launch of eight startups through its incubator program, and it has facilitated 43 IPOs and 39 M&A exits. Atlas operates with a global reach across the United States and Europe, supporting life science entrepreneurs in translating scientific advances into therapies and commercial opportunities.

Morningside Group is a venture capital firm founded in 1986, originally established as a family office for the Chan family, and is based in the greater Boston area. The firm makes venture investments in companies with novel science and technology, pursuing a long-term, patient approach to company-building and emphasizing ethical practices. Its investment focus spans life sciences, digital health, artificial intelligence, materials science, and information technology. In addition to its investment activities, Morningside supports charitable initiatives in education, research, and healthcare, with partnerships including the Harvard T.H. Chan School of Public Health, UMass Chan Medical School, and the MIT Morningside Academy for Design.

Alumni Ventures is a venture capital firm founded in 2014 and based in Manchester, New Hampshire. It connects accredited individual investors with startup deals and co-invests alongside established venture capital firms across multiple stages, from seed to growth. The firm provides access to diversified portfolios through funds, syndicates, and investing clubs, supported by a large network of community members and individual investors. It invests across sectors and geographies, with a focus on transparency and due diligence in collaborative investments with leading firms such as Andreessen Horowitz, Sequoia, and Y Combinator. Alumni Ventures operates internationally with offices in New York, Boston, Menlo Park, Chicago, London, and Tokyo and has raised substantial capital to back founders with strategic capital and resources.

Founded in 2000, Flagship Pioneering is a Cambridge, Massachusetts-based venture capital firm that conceives, creates, resources, and grows first-in-category companies in health technology, biotechnology, life sciences, and related fields. It accelerates advances in biology, engineering, medicine, energy, and beyond by combining scientific innovation with entrepreneurial leadership and professional capital management to bring seemingly unreasonable propositions through an evolutionary, company-building process. The firm focuses on developing and supporting early-stage ventures that aim to transform human health and sustainability.

Mission BioCapital is a life sciences venture capital firm established in 2009 and based in Cambridge, Massachusetts, that funds early-stage biotechnology companies and supports them through clinical development. The firm emphasizes mentorship and practical assistance, offering entrepreneurs access to laboratory space, incubator networks, and programs designed to accelerate progress and secure follow-on funding. Its approach combines capital with hands-on guidance across discovery, development, and commercialization, leveraging a history of supporting dozens of startups. Through a broad ecosystem in the United States and Europe, Mission BioCapital aims to translate scientific discoveries into tangible solutions by pairing funding with operational support, expert advice in areas such as drug discovery, legal, and accounting, and strategic mentorship to help portfolio companies reach milestones and attract subsequent investment.

Founder Collective is a venture capital firm founded in 2009 with offices in Cambridge, Massachusetts and New York. It focuses on seed and early-stage investments across sectors, prioritizing founder alignment and capital efficiency. The firm is built by founders and aims to support entrepreneurs from concept through outcomes, fostering a community of founders and sharing insights through articles and newsletters. While industry-agnostic, it backs technology-driven companies and maintains a globally active investment approach.

New Enterprise Associates is a venture capital firm founded in 1977 and based in Menlo Park, California, with a global investment reach. It provides capital and operational support to early, growth, and later-stage companies across a wide range of industries, including software, consumer technology, healthcare technology, life sciences, energy technology, infrastructure, and AI-enabled services. NEA collaborates with founders to address technical challenges, guide product development, and expand markets, leveraging its domain expertise to help portfolio companies scale from seed stages through IPO. The firm invests across the United States, Asia, and other regions, often supporting companies from early stages to scale, and has a long track record that includes numerous IPOs and acquisitions. NEA emphasizes a hands-on partnership approach and seeks opportunities across sectors that enable transformational businesses through technology and data-driven innovation.

Accomplice is a seed-led venture capital firm based in Cambridge, Massachusetts, focused on early-stage technology startups. It specializes in cybersecurity, esports, data analytics, SMB software, emerging hardware platforms, and marketplaces. The firm emphasizes a community-driven approach, leveraging networks such as AngelList to identify and fund founders and supporting them through collaborative programs. While most investments are in the Boston area, Accomplice backs companies across the United States, Canada, and the European Union. Originating as Atlas Venture, the technology group was renamed Accomplice in 2014, establishing a prominent early-stage presence in New England.

Founded in 1985, The Invus Group is a global private equity firm that partners with entrepreneurs, founders and management teams across the company lifecycle. Blending a family-office approach with multi-strategy investing, it supports transformative growth in sectors including consumer products and services, technology, life sciences, software, agtech, industrials, education and medical devices. The firm pursues long-term value creation through strategic insight, capital and execution, investing in companies from early stages to mature businesses and providing both lead investments and co-investments in private transactions worldwide. It maintains a global footprint with offices in New York, London, Paris and Hong Kong and has a flexible structure designed to align incentives with partners over time.

Alexandria Venture Investments is the strategic venture capital arm of Alexandria Real Estate Equities. It provides seed through growth capital to life science and technology companies developing breakthrough therapies, diagnostics, research tools, agrifoodtech, agtech, digital health, and related platforms. Backed by the parent company’s industry experience and scientific advisory network, the firm leverages long-standing relationships and domain expertise to support early to growth-stage ventures aiming to translate scientific advances into practical healthcare and technology solutions.

OrbiMed is a global healthcare investment firm based in New York that funds companies across the healthcare spectrum. It uses multiple strategies, including private equity for startups and growth-stage companies, private credit and royalty financing for intellectual property and medical diagnostics, and public equity investments. The firm targets biopharmaceuticals, biotechnology, medical devices, diagnostics, digital health, and health IT, supporting development of new therapies and health technologies. OrbiMed operates internationally with offices in major markets and manages substantial assets across public and private investments, staffed by a team of professionals to identify opportunities and support portfolio companies.

ARCH Venture Partners is a Chicago-based venture capital firm founded in 1986 that concentrates on science-driven startups, especially in life sciences, biotechnology, healthcare, and related technologies. It backs companies co-founded by scientists and entrepreneurs and supports commercialization of innovations developed at academic research institutions and national laboratories. The firm takes a long-term, hands-on approach, leveraging its network to assist portfolio companies from inception to market realization and to build transformative enterprises. ARCH has raised ten venture funds totaling over $3 billion and has invested in more than 150 companies worldwide, reflecting a focus on strategic value creation and governance.

F-Prime Capital is a venture capital firm based in Cambridge, Massachusetts, with a long history of investing in healthcare and technology companies. It backs early-stage and growth companies across life sciences, including therapeutics, medtech, and healthtech, and technology sectors such as enterprise software, fintech, frontier tech, and crypto, with a global reach across the Americas, Europe, and Asia. The firm manages about 4.8 billion in capital and relies on a multidisciplinary team of scientists, engineers, physicians, operators, and investors to help portfolio companies accelerate scalable growth. It also provides advisory support, leveraging deep sector expertise and operational experience to guide portfolio companies toward meaningful breakthroughs.

Eli Lilly and Company is a global biopharmaceutical company engaged in discovering, developing, manufacturing, and marketing medicines across neuroscience, cardiometabolic, cancer, and immunology. The company operates manufacturing and distribution facilities in the United States, Puerto Rico, and multiple countries, with products sold in about 135 markets worldwide. Through ongoing research and development, Lilly aims to deliver therapies that improve patient outcomes and access to medicines. Its portfolio includes treatments such as Mounjaro and Jardiance for cardiometabolic diseases, Verzenio and Jaypirca for cancer, Trulicity and Humalog for diabetes, and Taltz and Olumiant for immunology, among others. Lilly emphasizes safety and quality in manufacturing and supports patients through educational and support initiatives, reflecting a long history of pharmaceutical leadership and a commitment to advancing personalized medicine.

Spark Capital is an early-stage venture capital firm based in San Francisco with offices in Boston and New York City. It backs founders developing innovative products across all sectors and stages, guiding them to achieve success on their own terms. The firm has funded notable companies including Twitter, Discord, Anthropic, Cruise, Niantic, Oculus, Warby Parker and Tumblr, illustrating its willingness to back consumer, software, and technology leaders. Spark Capital emphasizes flexibility over prescriptive playbooks, supporting entrepreneurs from seed through growth rounds, and partners with portfolio companies to help scale products and go-to-market strategies while spanning sectors such as consumer, software, fintech, media, and education.

Matrix Partners is a venture capital firm founded in 1977 and based in San Francisco that funds early-stage technology companies. The firm focuses on applied AI, B2B software, fintech, health tech, infrastructure and hardware, and supports ventures from idea to Series A with a hands-on, founder-friendly approach drawn from its team of former entrepreneurs. It has backed and partnered with companies such as Apple, FedEx, Oculus, Canva, Zendesk and HubSpot, Postmates and Fivetran, illustrating a history of broad technology investments across the United States, China and India. Matrix Partners combines local knowledge with global experience to help portfolio companies scale into category-leading businesses.

North Bridge Venture Partners is a venture capital firm based in Needham, Massachusetts, founded in 1993. It provides seed-to-growth financing to startups in the United States operating in software, open source, cloud computing, e-commerce, big data and analytics, and mobile technologies, among others, helping transform ideas into market-leading businesses.

Casdin Capital is an investment firm focused on life sciences and healthcare. Founded in 2012 by Eli Casdin and based in New York, it seeks opportunities across the life sciences spectrum, including biotechnology, digital health, oncology, agtech, and healthcare services. The firm pursues early- to late-stage private investments and, at times, long-short equity strategies, leveraging data-driven insights, molecular information, and precision medicine to identify transformative opportunities. It emphasizes patient capital, disciplined investing, and strong collaborations to support companies advancing diagnostics, therapeutics, and sustainable solutions. By capturing and processing data to unlock breakthroughs, Casdin Capital backs teams with the potential to transform modern medicine.

Khosla Ventures is a California-based venture capital firm founded in 2004 and headquartered in Menlo Park. It provides capital and strategic guidance to technology companies across stages, investing in sectors including artificial intelligence, digital health, sustainability, climate tech, and consumer technology. The firm seeks startups with innovative technologies or business models and offers hands-on support to help build enduring companies. It manages multiple funds and runs initiatives such as Khosla Impact, which supports high-impact for-profit ventures addressing the needs of low-income populations and emerging markets. Through funding and guidance, it backs transformative technologies and scalable businesses in the United States and globally.

Deerfield Management is a New York-based healthcare investment firm established in 1994. It manages investments across public and private markets in healthcare products and services, including therapeutics, medical devices, diagnostics, digital health, and health services. The firm combines capital deployment with research and strategic intelligence through Deerfield Intelligence and supports innovation via Deerfield Discovery and Development (3DC) and a philanthropic foundation focused on education, healthcare access, and health outcomes.

Hyperplane Venture Capital is a Boston-based early-stage venture capital firm that backs technology companies developing machine intelligence, data solutions and related technologies. Founded in the mid-2010s, the firm seeks founders leveraging machine intelligence, sensor technology, and cloud computing to solve complex problems at the intersection of perception, communication, intelligence and insight. Its focus areas include artificial intelligence, machine learning, distributed systems, automation, cloud computing, ambient intelligence, robotics and immersive technologies such as virtual and augmented reality. Hyperplane partners with ambitious founders to support them through early-stage financing and strategic guidance as they transition from concept to scale.

Venrock is a Palo Alto-based venture capital firm with a history dating to 1969 as the venture capital arm of the Rockefeller family. It concentrates on technology and healthcare, providing seed and early-stage funding to entrepreneurs pursuing disruptive ideas. Its portfolio has included Apple, Intel, Illumina, Gilead Sciences, Nest, DoubleClick, Endeca, SlideShare, Athenahealth, and Tudou, among others, illustrating its experience across software, hardware, life sciences, and digital health. Venrock operates with a global perspective and maintains offices in Palo Alto, California and New York City, supporting startups through long-term partnerships and active involvement in company building.

SV Health Investors is a US-headquartered private equity and venture capital firm focused on healthcare and life sciences. Formerly known as SV Life Sciences, it invests in therapeutics, biotechnology, medtech, and healthcare growth companies across North America and Western Europe, with offices in Boston, San Francisco, and London. Founded in 1993, the firm aims to transform healthcare by backing entrepreneurs who develop breakthrough treatments and technologies, supported by a team of investment professionals and operating partners. It has managed billions of dollars in capital across private healthcare funds, pursuing a strategy that combines early-stage and growth investments and seeks value through strategic partnerships, acquisitions, and, when appropriate, public offerings. The firm operates as a dedicated partner to innovators in the sector, helping translate scientific advances into patient impact and commercial success.

.406 Ventures is a Boston-based venture capital firm that backs early-stage information technology and services companies, with emphasis on IT security and infrastructure, cloud and data, SaaS, cybersecurity, digital health, AI, fintech, and healthcare IT. It typically serves as lead investor in seed and Series A rounds, with initial investments of 2 to 5 million and total commitments around 6 to 10 million per company, and pursues board representation. The firm concentrates on the Northeast United States and leverages a veteran team of entrepreneurs and operators to provide strategic guidance, networks, and hands-on support to help portfolio companies grow and scale.

Third Rock Ventures is a Boston-based venture capital firm specializing in early-stage life sciences investments, including biotechnology, pharmaceuticals, medical devices, diagnostics, and therapeutics. The firm seeks high-growth opportunities and often leads initial rounds, supported by strategic collaborations with pharmaceutical and biotechnology partners. It takes an active role in portfolio companies, occasionally assuming key management positions, and focuses on United States–based companies with strong science and potential to transform healthcare.

Northpond Ventures is a science-driven venture capital firm specializing in growth capital, headquartered in Bethesda, Maryland, with offices in San Francisco, California, and Cambridge, Massachusetts. Founded in 2018, it focuses on life sciences and technology sectors, including diagnostics, digital health, health tech, therapeutics, and artificial intelligence and machine learning. The firm backs growth-stage companies advancing biomedical research and technology-enabled healthcare, aiming to translate scientific advances into commercial solutions.

Pillar VC is a Boston-based venture capital firm focused on early-stage technology startups. It was founded by a group of successful founders from companies such as Wayfair, Ginkgo Bioworks, DraftKings, Abridge, ButcherBox and Flywire. The firm partners with founders from inception to help build breakthrough companies that have the potential to shape the future. Pillar VC maintains a diverse portfolio of early-stage ventures, including many with university roots, and seeks to identify and back teams pursuing ambitious, transformative technologies while offering strategic guidance to accelerate product development and market entry.

Boston Seed Capital is a venture capital firm headquartered in the Boston area, with an office in Wellesley Hills, Massachusetts. Founded in 2010, it focuses on seed and early-stage investments in internet-enabled and technology-driven companies, including information technology, SaaS, cybersecurity, e-commerce, big data, marketplaces, esports, artificial intelligence and machine learning, as well as consumer goods and business services. The firm backs ventures across the United States, supporting early growth opportunities in consumer and technology sectors.

Mass General Brigham is an integrated academic health care system and Harvard Medical School teaching affiliate that comprises a network of hospitals and community health centers. It delivers a full continuum of patient care, advances biomedical research, and supports medical education, with a strong focus on health equity, workforce development, and community engagement. Founded more than 200 years ago, the system emphasizes innovation to improve patient outcomes and translates research into clinical practice across its member institutions.

SOSV is a global venture capital firm founded in 1995 and headquartered in New Jersey. The firm focuses on seed-to-growth investments in deep tech sectors, including biotech and life sciences, hardware and robotics, and cross-border software with emphasis on markets in Asia. It supports startups from early stages with investment capital as well as resources such as laboratories, collaborative spaces, and expert mentorship to accelerate product development and market traction. SOSV operates purpose-built programs to help portfolio companies raise follow-on funding, scale operations, and reach customers, often through structured matchmaking and access to a global network of investors. With a broad portfolio spanning hundreds of companies worldwide, SOSV aims to foster innovation, build vibrant entrepreneurial ecosystems, and contribute to sustainable technological advancement.

Launchpad Venture Group is a Boston-based angel investment group and venture capital firm focused on funding early-stage technology and life science companies in the United States, with a particular emphasis on New England. It provides both financial capital and human capital—mentorship, guidance, and investment acumen—to startups addressing innovative, tech- and science-driven opportunities. The firm supports a broad range of sectors including software, information technology, web and mobile, e-commerce, media and social platforms, medical devices, diagnostics, healthcare IT, networking and telecom, and cleantech. It promotes a culture of learning and service, facilitating streamlined deal evaluation and active engagement with portfolio companies. Annual activity includes multiple rounds totaling several million dollars, illustrating a hands-on approach to helping entrepreneurs grow sustainable businesses.

Safar Partners is a venture capital investment firm based in Cambridge, Massachusetts, founded in 2018. The firm concentrates on seed- to growth-stage technology companies, with a focus on cleantech, advanced materials, artificial intelligence and IT, robotics, and life sciences including medical devices. It sources opportunities from MIT, Harvard, and the University of Rochester and primarily invests in United States-based startups. Safar Partners operates as a registered investment adviser.

Beacon Angels is a Boston-based angel investment group established in 2006 that backs early-stage and fast-growing companies in New England. The group typically provides capital in the range of $100,000 to $300,000 to support growth, product development, and market expansion.

Samsara BioCapital is a venture capital firm based in Palo Alto, California, that invests in biotechnology and healthcare companies across the United States. The firm supports biotech ventures by providing capital and strategic guidance to help advance innovative therapies and discoveries. It operates as a registered investment adviser, offering investment advisory services to entrepreneurs and venture teams as they work to bring new biotech solutions to market.

E14 Fund is a venture capital firm affiliated with MIT that backs scalable, deep-tech startups founded by MIT alumni, faculty, and students. The firm provides early-stage capital, typically in the range of one to five million dollars, with potential follow-on funding, and leverages the MIT ecosystem and a network of advisors to help portfolio companies move technologies from lab to market across fields such as artificial intelligence and computing, hardware and robotics, physics and materials, and biology. The organization actively supports the MIT startup community and connects entrepreneurs with investors, industry experts, and mentors to accelerate growth.

Underscore VC is a Boston-based venture capital firm that backs early-stage technology startups across the United States, from pre-seed to Series A. The firm concentrates on enterprise software and B2B applications, with interests in artificial intelligence and machine learning, vertical SaaS, fintech, insurtech, healthtech, e-commerce, and related cloud and data infrastructure. It targets companies leveraging cloud platforms, data storage, and software for industries such as manufacturing, home automation, and healthcare, and seeks opportunities in infrastructure and cloud-enabled solutions for marketing and commerce. Underscore VC emphasizes an open, collaborative approach, leveraging a Core Community of founders and executives to align incentives with portfolio companies and provide guidance. Based in Boston, the firm aims to connect startups with the region’s innovation ecosystem while applying a broad U.S. footprint to identify ambitious teams and scalable technology businesses.

Novo Nordisk is a global healthcare company focused on discovering, developing, and delivering medicines for serious chronic diseases, with a core emphasis on diabetes care. The organization produces and distributes insulin and other therapies aimed at treating diabetes and related conditions, while investing heavily in scientific research and biopharmaceutical innovation. Through partnerships and sustained commitments to accessibility, Novo Nordisk seeks to improve patient outcomes and support health systems worldwide. The company operates across many markets, supported by its production of insulin pens and a broad portfolio addressing obesity, rare blood and endocrine disorders, and other chronic diseases. It pursues long-term social responsibility and sustainability as integral to its business model.

CVP Management is a venture capital firm focused on early‑stage technology investments, including seed and early Series A rounds. It concentrates on information technology infrastructure with emphasis on software applications, internet, digital media, digital marketing, vertical SaaS, cloud, embedded software, mobile, and financial services technologies. The firm typically invests from $0.1 million to $1 million, and for seed and Series A rounds from $1 million to $3.5 million, in companies with an enterprise value around $5 million. It prefers to hold a seat on the portfolio company board and to invest in preferred stock. The firm funds companies located in the Northeast corridor, especially Boston, New York, and Toronto, and began operation on June 1, 1998, with headquarters in Cambridge, Massachusetts, and an additional office in Boston.

Logos Capital is a biotechnology-focused investment firm headquartered in San Francisco. The company applies disciplined, data-driven diligence across medical, scientific, and clinical disciplines to identify transformative therapies in healthcare. By combining in-house analytics with rigorous clinical evaluation, Logos Capital seeks to back life-changing therapeutics with strong value propositions. The firm emphasizes rigorous opportunity identification, thorough clinical trial underwriting, and proactive risk management, leveraging advanced analytics to predict trial outcomes and support informed investment decisions. Its approach aims to deliver compelling returns while contributing to patient outcomes by supporting companies with transformative technologies.

Lux Capital is a New York-based venture capital firm founded in 2000 that funds seed- and early-stage companies, with occasional growth investments, in science- and engineering-driven sectors. It backs ventures applying scientific research to commercial applications across artificial intelligence, biotechnology, advanced materials, electronics, aerospace and space technology, satellites, drones, robotics, synthetic biology, genomics, 3D printing, and related infrastructure. The firm provides capital alongside strategic input on product development, team building and long-term positioning, taking an active role to help translate complex innovations into scalable businesses. With offices in New York and Silicon Valley, Lux has helped launch more than 20 companies and manages several billion dollars in assets. It emphasizes deep scientific insight, cross-disciplinary collaboration, and an early-stage focus, aiming to connect portfolio companies with markets and industry leadership.

Refactor Capital is a venture capital firm based in Burlingame, California, founded in 2016. It concentrates on seed- and early-stage investments in hard technology, biotechnology, and health, with a breadth of sectors including energy, earth systems, aerospace, manufacturing, and critical materials. The firm is led by Zal Bilimoria as sole general partner.

Fontinalis Partners is a Detroit-based venture capital firm focused on mobility and related technology. With offices in Detroit and Boston, it invests across the next-generation mobility ecosystem, spanning connected vehicles, data and analytics, intelligent infrastructure, location-based services, mobility transactions, and new mobility models such as car sharing and ride sharing. The firm partners with founders from pre-seed through growth rounds, adopting a stage-agnostic approach and often taking board seats to support strategic growth. It leverages extensive management experience, market access, and international networks to help portfolio companies scale globally within multi-modal transportation systems that may include road, rail, air, and maritime. Fontinalis also considers software, analytics, and cloud-based solutions that enable mobility. The firm emphasizes long-term partnerships and is not affiliated with Ford Motor Company.

Clean Energy Ventures is a venture capital firm focused on accelerating climate technology startups at seed and early stages. Based in Boston, Massachusetts, it backs companies developing advanced energy technologies and innovative business models to reduce greenhouse gas emissions. The firm invests in sectors such as energy storage, grid connectivity, renewable energy, clean transportation and related water and energy nexus initiatives, with a geographic focus on the United States and Canada and a broader reach into Europe and Israel. It complements capital with mentorship, strategic guidance and access to a wide network of industry experts to help portfolio companies scale and deploy transformative clean energy solutions.

Gutbrain Ventures is a Boston-based independent venture firm focused on investing in enterprise software. Descriptions from multiple sources place its founding in the 2010s (noting years such as 2011 and 2018), and identify Bob Davoli as its founder. The firm seeks paradigm-shifting opportunities by evaluating founders, people and technology, favoring passionate teams with disruptive ideas. It emphasizes long-term partnerships, offering strategic guidance and operational insights, with support across a company's lifecycle from early stages to exits and IPO candidacy, aiming to drive value across diverse sectors.

CRV, formerly Charles River Ventures, is an early-stage venture capital firm founded in 1970. Headquartered in Palo Alto, California, it maintains offices in Cambridge, Massachusetts, and Menlo Park, California. The firm targets seed to Series B investments across technology, consumer goods and healthcare in North America. CRV employs a hands-on, value-added approach, acting as a trusted partner to founders throughout a company's growth. As one of the oldest active venture firms, CRV has managed about $1.5 billion and supports portfolio companies with strategic guidance and operational insight to help them scale from inception onward.

Longwood Fund is a Boston-based venture capital firm that invests in science-based healthcare and biotechnology companies, aiming to develop novel solutions for medical problems. Founded in 2010, the firm supports early-stage research through to market commercialization by partnering with exceptional scientific co-founders and leveraging a deep network in the biotechnology ecosystem. Longwood Fund focuses on healthcare, pharmaceuticals, and life sciences, seeking to create patient impact and investor value by guiding portfolio companies from discovery to commercialization.